TScan Therapeutics, Inc.'s latest layoff filing, on September 2, 2026, states a cut of about 75% of its workforce. TScan Therapeutics, Inc. trades on Nasdaq as TCRX. As of November 6, 2026, it has reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, September 2, 2026).
Who owns TScan Therapeutics, Inc.?
12 companies announced layoffs this week.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| Artiva Biotherapeutics, Inc. | announced layoffs | |
| Eos Energy Enterprises, Inc. | announced layoffs | |
| SOUNDHOUND AI, INC. | announced layoffs | |
| Portillo's Inc. | announced layoffs | |
| Acumen Pharmaceuticals, Inc. | announced layoffs of about 52 employees |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of TScan Therapeutics, Inc.
Free to see. No signup.
TScan Therapeutics, Inc. reported 2 exit or restructuring plans on Form 8-K under Item 2.05, 1 of 2 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did TScan Therapeutics have layoffs in 2026? What its filings say
TScan Therapeutics, Inc. (CIK 1783328) reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2026-09-02
Share of workforce
Pursuant to such strategy, the Company also implemented a workforce reduction of approximately 75% of the Company's workforce (the "Strategic Reorganization").
Timing
The Company expects to substantially complete the Strategic Reorganization by the end of the fourth quarter of 2026.
Form 8-K filed 2025-11-03
Employees affected
Pursuant to such strategy, the Company also implemented a workforce reduction of approximately 30% of the Company's workforce, or 66 roles.
Expected charges
The Company expects to record a one-time charge of up to approximately $2.3 million during the three months ended December 31, 2025, for severance-related benefits and other costs.
Also on the record for TScan Therapeutics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 16, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| September 25, 2026 | Stake report, Schedule 13G, by Readout Capital, LP | 5.4% of the class | 5%+ stakes | Source |
| September 11, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| September 2, 2026 | Leadership change: Jason A. Amello departs, Chief Financial Officer | — | Leadership changes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL | 9.99% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Lynx1 Capital Management LP | 13.1% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL | 9.99% of the class | 5%+ stakes | Source |
| April 2, 2026 | Leadership change: Leiden Dworak departs, Vice President, and 1 more | — | Leadership changes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Lynx1 Capital Management LP | 15% of the class | 5%+ stakes | Source |
| August 12, 2025 | Stake report, Schedule 13G/A, by Adage Capital Management, L.P. | 2.52% of the class | 5%+ stakes | Source |
| July 16, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 1.8% of the class | 5%+ stakes | Source |
Keep reading
More on TScan Therapeutics, Inc. and the records around it.
TScan Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
- Leadership changes Sep 2026
- Who owns it
Companies that share a holder
- Readout Capital, LP also filed stake reports on 1 other company: PRECISION BIOSCIENCES INC (Aug 2025)
- Lynx1 Capital Management LP also filed stake reports on 11 other companies: C4 Therapeutics, Inc. (Aug 2026), GH Research PLC (Aug 2026), iBio, Inc. (Aug 2026)
- BIOTECHNOLOGY VALUE FUND L P also filed stake reports on 55 other companies: Frazier Life Sciences Acquisition Corp. II (Oct 2026), Olema Pharmaceuticals, Inc. (Oct 2026), Foghorn Therapeutics Inc. (Oct 2026)
Watch TScan Therapeutics, Inc.
Get an email when TScan Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with TScan Therapeutics, Inc.?
Want the whole picture on TScan Therapeutics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on TScan Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TScan Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for TScan Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Cite this page
https://mentionfox.com/layoffs/tscan-therapeutics